LifeSciVC

AUGUST 5, 2024

We are constantly reminded how we are in the midst of an artificial intelligence revolution of the drug development process which promises to completely transform how we develop drugs with increases in productivity of an order of magnitude or more.

Molecular Biology 87

Molecular Biology Production Small Molecule Drug Development 87

Drug Discovery World

JULY 23, 2024

Importantly, only a small fraction of the human genome codes for proteins; the majority (~ 98%) consists of non-coding DNA, which plays a critical role in gene regulation, cellular identity, and disease susceptibility. Therefore, it is highly likely that deciphering the mechanism of action of enhancers is key to understanding human disease.

DNA 130

DNA Disease Regulations Molecular Biology 130

Drug Discovery World

MAY 6, 2024

Even before this, however, Amsterdam was established as an important centre for drug development. The company is now investigating a promising gene therapy for Huntingdon’s disease in a Phase I/II trial, with patients already showing signs of preserved neurological function. The CDD will sponsor and manage KWF-supported trials.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

DECEMBER 26, 2023

Makoto Inoue, President and Representative Director of Otsuka Pharmaceutical commented: “Otsuka is committed to the development of drugs for rare diseases such as autosomal dominant polycystic kidney disease (ADPKD). His research focuses on immunotherapies for patients with breast cancer.

Small Molecule 130

Small Molecule Drugs Molecular Biology Bioinformatics 130

Drug Discovery World

MARCH 12, 2024

RA: What advantages does a plant-based approach bring to drug development? These confounding factors limit the opportunity for big pharma, especially considering the poor access to the complex small molecule pharmacophores known to have a link to the target disease and from which drug discovery programmes can be rolled out.

Small Molecule 147

Small Molecule Synthetic Chemistry Production Molecular Biology 147

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. from 2024 to reach US$129.8

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Drug Discovery World

APRIL 30, 2024

Messenger RNA (mRNA) has come into focus within the drug discovery and development as an exciting tool to deliver genetic information. Whilst research into mRNA has been ongoing for decade, interest has sparked in recent years and research has begun to expand into areas of vaccinology, infectious diseases and other indications.

Therapies 130

Therapies RNA Vaccine Small Molecule 130